08037 CH BIOTECH SER
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.23X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 77.2% | Net Margin | N/A |
| Total Debt/Equity | 206.3% | Return on Equity | N/A |
| Price/Book | 3.52X | Return on Assets | N/A |
| (HKD 0.690) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | -68.78 | -198.15 | -95.45 | 258.09 | 19.39 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +65.3 | -107.6 | -137.0 | +1,231.4 | -35.8 |
| Earnings Per Share (HKD) | -0.071 | -0.205 | -0.099 | 0.268 | 0.02 |
| Earnings Per Share Growth (%) | +65.5 | -106.5 | -137.0 | +1,232.8 | -35.6 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | 0.010 | No dividend |
| P/E* (X) | N/A | N/A | N/A | 2.58 | 34.33 |
| Yield (%) | N/A | N/A | N/A | 1.45 | N/A |
| Dividend Share (%) | N/A | N/A | N/A | 3.73 | N/A |
| Book NAV (HKD) | 0.196 | 0.272 | 0.480 | 0.626 | 0.411 |
| Auditors' Opinion | N/A | Qualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (HKDMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 73.503 | 70.509 | +4.2 | 211.985 |
| Operating Result | -81.697 | -252.689 | -67.7 | -134.641 |
| Associates | 0 | 0 | N/A | -7.678 |
| Profit Before Taxation | -81.697 | -252.797 | -67.7 | -142.025 |
| Taxation | -0.856 | -0.943 | -9.2 | -1.319 |
| Profit /( Loss) After Taxation | -80.841 | -251.854 | -67.9 | -140.706 |
| Minority Interests | -12.063 | -53.708 | -77.5 | -45.259 |
| Net Profit | -68.778 | -198.146 | -65.3 | -95.447 |
| Earnings Per Share () | -0.0705 | -0.2046 | -65.5 | -0.0991 |
| Dividend Per Share () | 0.0000 | 0.0000 | N/A | 0.0000 |
| Announcement Date | 2026-03-27 | 2025-03-28 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
